- Home
- LMAT vs OCUL Comparison
LMAT vs OCUL Comparison
Compare LMAT & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMAT
- OCUL
- Stock Information
- Founded
- LMAT 1983
- OCUL 2006
- Country
- LMAT United States
- OCUL United States
- Employees
- LMAT N/A
- OCUL N/A
- Industry
- LMAT Medical/Dental Instruments
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- LMAT Health Care
- OCUL Health Care
- Exchange
- LMAT Nasdaq
- OCUL Nasdaq
- Market Cap
- LMAT 2.0B
- OCUL 2.3B
- IPO Year
- LMAT 2006
- OCUL 2014
- Fundamental
- Price
- LMAT $89.13
- OCUL $11.51
- Analyst Decision
- LMAT Buy
- OCUL Strong Buy
- Analyst Count
- LMAT 6
- OCUL 9
- Target Price
- LMAT $99.67
- OCUL $22.63
- AVG Volume (30 Days)
- LMAT 110.3K
- OCUL 3.4M
- Earning Date
- LMAT 11-06-2025
- OCUL 11-04-2025
- Dividend Yield
- LMAT 0.89%
- OCUL N/A
- EPS Growth
- LMAT 22.69
- OCUL N/A
- EPS
- LMAT 2.05
- OCUL N/A
- Revenue
- LMAT $234,639,000.00
- OCUL $56,664,000.00
- Revenue This Year
- LMAT $16.27
- OCUL N/A
- Revenue Next Year
- LMAT $8.61
- OCUL $17.75
- P/E Ratio
- LMAT $43.72
- OCUL N/A
- Revenue Growth
- LMAT 14.11
- OCUL N/A
- 52 Week Low
- LMAT $71.42
- OCUL $5.79
- 52 Week High
- LMAT $109.58
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- LMAT 51.19
- OCUL 46.21
- Support Level
- LMAT $87.59
- OCUL $11.38
- Resistance Level
- LMAT $90.62
- OCUL $11.78
- Average True Range (ATR)
- LMAT 1.91
- OCUL 0.48
- MACD
- LMAT 0.42
- OCUL -0.01
- Stochastic Oscillator
- LMAT 70.64
- OCUL 32.93
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.